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Introduction
Chronic neuropathic pain remains an unmet clinical problem because available treatments have limited efficacy in many patients. Neuropathic pain is typically caused by a lesion or dysfunction of the peripheral or central nervous system. The proposed mechanisms of neuropathic pain include increased primary afferent excitability (Gracely et al., 1992; Matzner and Devor, 1994) , increased glutamatergic input to dorsal horn neurons (Kohno et al., 2003; Wang et al., 2007) , and diminished GABAergic inhibition due to a depolarizing shift in the anion gradient of dorsal horn neurons (Coull et al., 2003; Coull et al., 2005) . The dorsal horn of the spinal cord is a crucial site for pain transmission and modulation (Cervero and Iggo, 1980) . A better understanding of the cellular and molecular mechanisms that regulate the synaptic transmission in the spinal dorsal horn is critical for developing more effective treatments for neuropathic pain.
Increased glutamatergic synaptic inputs to spinal dorsal horn neurons play a pivotal role in the development and maintenance of central sensitization and neuropathic pain conditions (Kohno et al., 2003; Wang et al., 2007; Zhang et al., 2009 ). Glutamate is a major excitatory neurotransmitter released from primary afferents and interneurons in the spinal cord. Glutamate acts on both ionotropic and metabotropic receptors (mGluRs). mGluRs are involved in synaptic plasticity at various levels of the nervous system (Anwyl, 1999) . Eight mGluRs have been cloned and classified into group I (mGluR1 and 5), group II (mGluR2 and 3), and group III (mGluR4, 6, 7, and 8) (Anwyl, 1999; Schoepp et al., 1999) . Group I mGluRs are coupled to Gq/11 proteins, leading to activation of phospholipase C and increased neuronal firing and synaptic transmission. Group II and III mGluRs, however, are typically coupled to inhibitory Gi/o proteins, thereby inhibiting cAMP formation and voltage-gated Ca 2+ channels to reduce neuronal excitability and synaptic transmission (Conn and Pin, 1997; Anwyl, 1999) . Group II mGluRs (mGluR2/3) are very difficult to separate from each other with use of pharmacological approaches, because their proteins share so much sequence similarity. Group II mGluRs are present in the dorsal root ganglion and spinal superficial dorsal horn (Jia et al., 1999; Carlton et al., 2001) , and stimulation of these mGluRs in the spinal cord generally depresses synaptic transmission (Gerber et al., This article has not been copyedited and formatted. The final version may differ from this version. Zhou et al., 2007) . We have demonstrated that activation of group I and group III mGluRs has distinct effects on synaptic transmission in the spinal dorsal horn in neuropathic pain Zhang et al., 2009; Li et al., 2010) . In contrast, the nerve injury-induced changes in group II mGluR function in the spinal dorsal horn and their functional significance in neuropathic pain are still not clear.
We, therefore, conducted the present study to determine the functional plasticity of group II mGluRs in the control of excitatory and inhibitory synaptic transmission in the spinal dorsal horn in a rat model of neuropathic pain. Our findings provide new information that nerve injury increases the function of group II mGluRs located on glutamatergic and glycinergic interneurons in the spinal dorsal horn.
Furthermore, we found that stimulation of spinal group II mGluRs attenuates neuropathic pain, probably by preferential inhibition of synaptic glutamate and glycine release to dorsal horn neurons.
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Methods
Animal model of neuropathic pain and intrathecal cannulation
Male Sprague-Dawley rats (180-200 g; Harlan, Indianapolis, IN) were used in this study. All the surgical preparation and experimental protocols were approved by the Animal Care and Use
Committee of the University of Texas MD Anderson Cancer Center and conformed to the National Institutes of Health guidelines for the ethical use of animals. L5 and L6 spinal nerve ligation was used as an experimental model of neuropathic pain in our study (Kim and Chung, 1992) . We induced anesthesia with 2-3% isoflurane and then isolated the left L5 and L6 spinal nerves and ligated them tightly with 5-0 silk suture. Sham animals used as controls underwent similar surgical procedures except nerve ligation. In animals used for behavioral studies, intrathecal catheters (PE-10 polyethylene tubing) were implanted one week after sham or nerve ligation surgery. The catheters were advanced 8 cm caudally through an incision in the cisternal membrane and secured to the musculature at the incision site. Only animals with no evidence of neurological deficits after catheter insertion were studied.
DCG-IV was administered in a volume of 5 μ l followed by a 10-μl flush with normal saline. Final behavioral tests and electrophysiological recordings were performed 3-4 weeks after surgery.
Behavioral assessment of nociception in rats
To quantify tactile allodynia, rats were placed in individual plastic boxes on a mesh floor and allowed to acclimate for 30-45 min. A series of calibrated von Frey filaments was applied perpendicularly to the plantar surface of the hindpaw with sufficient force to bend the filaments for 6 s.
Brisk paw withdrawal or flinching was considered a positive response. In the absence of a response, the filament of next greater force was applied. If a response occurred, the filament of next lower force was applied. The tactile stimulus producing a 50% likelihood of withdrawal was determined by using the "up-down" calculating method (Chaplan et al., 1997; Chen et al., 2000) . Tactile allodynia was confirmed in all rats subjected to spinal nerve ligation.
The paw pressure test was used to quantify the mechanical nociceptive threshold of the 
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7 hindpaw (mechanical hyperalgesia) Chen et al., 2009b) . Nociceptive thresholds, expressed in grams, were measured with use of an analgesimeter (Ugo Basile, Varese, Italy). The test was performed by applying a pressure stimulus to the hindpaw. When a pedal that activates a motor was pressed, the force increased on a linear scale at a constant rate. When the animal showed pain by withdrawal of the paw or vocalization, the pedal was released and the nociceptive pain threshold was read on a scale.
Spinal cord slice preparation
Under 2-3% isoflurane anesthesia, the lumbar segment of the spinal cord was removed through laminectomy. 
Electrophysiological recordings
Recordings of postsynaptic currents were performed by using the whole-cell voltage-clamp method, as we described previously (Zhou et al., 2008a; Zhang et al., 2009; Zhou et al., 2009 of the dorsal root (Zhou et al., 2008a; Zhang et al., 2009) . Because the retained dorsal root was very short, we did not measure the conduction velocity of afferent fibers stimulated. At the stimulation intensity used, both A-and C-afferent fibers that are in close contact with the electrode tip are stimulated (Wang et al., 2007; Zhou et al., 2010) . The eEPSCs were considered monosynaptic if the latency was constant after electrical stimulation (0.2 Hz) and if no conduction failure or increased latency occurred when stimulation frequency was increased to 20 Hz. In contrast, the latency of polysynaptic eEPSCs varied and conduction failure occurred when the stimulation frequency was increased to 20 Hz (Li et al., 2010; Zhou et al., 2010) . 
Data analysis
Data are presented as the means ± S.E.M. The effects of DCG-IV and EGLU on the paw withdrawal thresholds were compared by using repeated measures analysis of variance followed by Tukey's post hoc test. The sEPSCs, mEPSCs, sIPSCs, and mIPSCs were analyzed off-line with a peak detection program (MiniAnalysis, Synaptosoft, Decatur, GA). Measurements of the amplitude and frequency of sEPSCs, mEPSCs, sIPSCs, and mIPSCs were performed during control, drug application, and recovery. The cumulative probability of the amplitude and inter-event interval of sEPSCs, mEPSCs, sIPSCs, and mIPSCs was compared with use of the Komogorov-Smirnov test, which estimates the probability that two cumulative distributions are similar. Analyses of the effect of DCG-IV on the amplitude of eEPSCs were performed by using Clampfit 9.2 (Axon Instruments). Neurons were considered to be inhibited by DCG-IV if the amplitude of eEPSCs was reduced > 15%. Differences were determined by repeated measures analysis of variance or two-way analysis of variance. P < 0.05 was considered to be statistically significant. 
Results
Effect of DCG-IV on glutamatergic monosynaptic and polysynaptic EPSCs in nerve-injured rats
To determine the role of group II mGluRs in the control of glutamatergic input from primary afferents to dorsal horn neurons in sham and nerve-injured rats, we tested the effect of the group II mGluR agonist DCG-IV on monosynaptic eEPSCs elicited from the dorsal root. DCG-IV is a highly specific agonist of mGluR2/3 (Ishida et al., 1993b; Hayashi et al., 1994; Gerber et al., 2000) . LY354740
has an affinity in the nanomolar range for group II mGluRs (Schoppa and Westbrook, 1997; Monn et al., 1999; Schoepp et al., 1999) . However, we did not choose LY354740 for our study because it has a weak agonist effect on mGluR6 and mGluR8 (Wu et al., 1998; Monn et al., 1999) . In nerve-injured rats, the baseline amplitude of monosynaptic eEPSCs of lamina II neurons elicited from the dorsal root (i.e., glutamatergic input from primary afferents) was significantly larger than that in sham rats ( The baseline amplitude of polysynaptic eEPSCs from the dorsal root (i.e., mixed glutamatergic input from primary afferents and interneurons) was also significantly larger in the nerve-injured group than in the sham group (275.08 ± 22.73 vs. 251.03 ± 13.63 pA; Fig. 1D ). DCG-IV (1-10 μ M) inhibited the amplitude of polysynaptic eEPSCs in a concentration-dependent fashion in both the sham and nerve-ligated rats (Fig. 1D) . Although the incidence of inhibition of polysynaptic eEPSCs of lamina II neurons by DCG-IV was similar in the sham (10 of 15 neurons, 66.7%) and in nerve-injured (9 of 14 neurons, 64.3%) groups, the magnitude of inhibition of the amplitude of polysynaptic eEPSCs by DCG-IV was significantly greater in nerve-injured rats than in sham control rats (Fig. 1D) . At 3
This article has not been copyedited and formatted. The final version may differ from this version. DCG-IV inhibited 36.6 ± 3.3% and 19.7 ± 4.1% of the amplitude of polysynaptic eEPSCs in nerve-injured and control rats, respectively.
Some studies have reported that DCG-IV, at a high concentration, might produce its effect via activation of NMDA receptors (Ishida et al., 1993a; Breakwell et al., 1997) . eEPSCs to a degree that was similar to DCG-IV alone in nerve-injured rats (Fig. 1E ). These results suggest that glutamatergic input from primary afferents to spinal dorsal horn neurons is augmented after nerve injury. Furthermore, our data suggest that nerve injury increases the activity of group II mGluRs expressed on glutamatergic interneurons in the spinal dorsal horn.
Effect of DCG-IV on glutamatergic sEPSCs and mEPSCs in control and nerve-injured rats
To further determine the role of group II mGluRs in the control of glutamatergic transmission in the spinal dorsal horn, we examined the effect of DCG-IV on glutamatergic sEPSCs and mEPSCs in lamina II neurons of sham and nerve-injured rats. There were no significant differences in the baseline amplitude (18.81 ± 1.39 vs. 19.91 ± 1.45 pA) or frequency (7.54 ± 0.83 vs. 7.92 ±0.34 Hz) of sEPSCs between the sham and nerve-injured groups (Fig. 2, A-E). Bath application of 3 μ M of DCG-IV for 3 min significantly inhibited the frequency, but not the amplitude, of sEPSCs in all 13 neurons from sham rats and all 16 neurons from nerve-injured rats (Fig. 2, A-F) . The cumulative probability analysis of sEPSCs revealed that the distribution pattern of the inter-event interval of sEPSCs was shifted toward the right in response to DCG-IV (Fig. 2, C and D) . When the effect of DCG-IV on sEPSCs was normalized to baseline, the magnitude of inhibition of the sEPSC frequency by DCG-IV was significantly greater in nerve-injured rats than in sham control rats (Fig. 2F) . In sham and nerve-injured groups, bath application of EGLU (200 μ M), a highly specific group II mGluR antagonist (Jane et al., 1996; Schoepp et al., 1999) , for 3 min alone had no significant effect on sEPSCs. EGLU completely blocked the 
Effect of DCG-IV on GABAergic sIPSCs and mIPSCs of lamina II neurons in control and nerve-injured rats
The basal frequency (1.13 ± 0.15 vs. 1.25 ± 0.14 Hz) of GABAergic sIPSCs of lamina II neurons in nerve-injured rats was similar to that in sham rats (Fig. 3) . However, the amplitude of GABAergic sIPSCs in the nerve-injured group (13.29 ± 0.81 pA) was significantly smaller than that in the sham group (15.86 ± 1.21 pA, Fig. 3F ). DCG-IV (0.3-10 μ M) decreased the frequency, but not the amplitude, of GABAergic sIPSCs in a concentration-dependent manner in all 10 neurons from the sham control group and all 12 neurons from the nerve-ligated group (Fig. 3E) . The cumulative probability analysis of GABAergic sIPSCs revealed that the distribution pattern of the inter-event interval of sIPSCs was shifted toward the right in response to DCG-IV. However, the inhibitory effect of DCG-IV on the frequency of GABAergic sIPSCs did not differ significantly between the two groups.
The baseline frequency (0.92 ± 0.06 vs. 0.96 ± 0.09 Hz) of GABAergic mIPSCs was also similar in sham and nerve-injured rats (Fig. 4) . However, the amplitude of GABAergic mIPSCs was significantly reduced in the nerve-injured (10.59 ± 0.42 pA) group compared with that in the sham control (14.15 ± 1.76 pA) group (Fig. 4F ). Bath application of 3 μ M DCG-IV significantly decreased the frequency, but not the amplitude, of mIPSCs in all 9 cells from the sham control group and all 12 cells from the nerve-ligated group (Fig. 4E) . The inhibitory effect of DCG-IV on the frequency of GABAergic mIPSCs μ M DCG-IV inhibited the frequency of sIPSCs more than that of mIPSCs in both groups. These data suggest that although nerve injury attenuates GABAergic inhibitory input to spinal dorsal horn neurons, the activity of group II mGluRs expressed on GABAergic interneurons is not altered in this animal model of neuropathic pain.
Effect of DCG-IV on glycinergic sIPSCs and mIPSCs of lamina II neurons in control and nerve-injured rats
The baseline frequency of glycinergic sIPSCs of lamina II neurons did not differ significantly between the sham control and nerve-injured groups (Fig. 5) . However, the baseline amplitude of glycinergic sIPSCs was significantly reduced in nerve-injured rats compared with that in sham rats ( (Fig. 5F ).
Furthermore, the frequency of glycinergic mIPSCs of lamina II neurons did not differ significantly between the sham control and nerve-injured groups (Fig. 6) . However, the baseline amplitude of glycinergic mIPSCs was significantly reduced in nerve-injured rats compared with that in sham rats (Fig.   6F ). Bath application of 3 μ M DCG-IV significantly decreased the frequency, but not the amplitude, of mIPSCs in all 11 cells from the nerve-ligated group (Fig. 6E) . In contrast, DCG-IV had no significant effect on the frequency or amplitude of glycinergic mIPSCs in all 11 neurons from the sham control group (Fig. 6E) . Notably, DCG-IV (3 μ M) reduced the sIPSC frequency more than the frequency of glycinergic mIPSCs in nerve-injured rats (Fig. 5E ). These findings suggest that nerve injury reduces glycinergic input to spinal dorsal horn neurons and induces the expression of group II mGluRs on glycinergic interneurons and their terminals in the spinal dorsal horn. EGLU abolished the effect of DCG IV on tactile allodynia in nerve-injured rats (Fig. 7A ).
Intrathecal administration of DCG-IV also dose-dependently increased the paw withdrawal threshold in response to the noxious pressure stimulus in nerve-injured rats (Fig. 7B) . Surprisingly, intrathecal injection of DCG-IV significantly reduced the pressure withdrawal threshold in sham rats in a dose-dependent manner (Fig. 7C) . In both groups, the peak effect of DCG-IV appeared within 
Discussion
In this study, we determined the functional plasticity of spinal group II mGluRs in the regulation of excitatory and inhibitory synaptic transmission in neuropathic pain. We found that the amplitude of monosynaptic and polysynaptic eEPSCs evoked from primary afferents was significantly larger in spinal nerve-injured rats than in control rats. This finding suggests that nerve injury increases the glutamatergic input from primary afferents to spinal dorsal horn neurons. Our results are consistent with previous studies showing augmented glutamatergic input from primary afferents in neuropathic pain induced by nerve ligation and diabetic neuropathy in rats (Kohno et al., 2003; Wang et al., 2007; Zhang et al., 2009) . The study by Moore et al (2002) did not find any difference in the amplitude of primary afferent-evoked EPSCs of lamina II neurons in their nerve injury models. However, there are some major technical differences between their and our studies (e.g., suction vs. bipolar electrode, long vs. short dorsal root, blind vs. visualized recording, and recording at L4 vs. L5/L6 levels). Increased excitability of primary afferent nerves and ectopic discharges from injured afferent nerves (Gracely et al., 1992; Matzner and Devor, 1994) can result in enhanced glutamatergic input from primary afferents. Also, nerve injury reduces the expression and activity of voltage-activated and Ca 2+ -activated K + channels in primary sensory neurons (Everill and Kocsis, 1999; Kim et al., 2002; Sarantopoulos et al., 2007; Chen et al., 2009a) .
GABA and glycine are the two major inhibitory neurotransmitters in the normal spinal cord.
Reduced GABA-and glycine-mediated inhibition (disinhibition) may also contribute to the hyperexcitability of spinal dorsal horn neurons and pain sensitivity. For instance, blocking spinal GABA A receptors produces tactile allodynia in rats (Sorkin et al., 1998) . Also, blockade of glycine receptors in the spinal cord leads to hypersensitivity of spinal dorsal horn neurons and allodynia in rats (Yaksh, 1989) . We found that the baseline amplitude, but not the frequency, of GABAergic and glycinergic sIPSCs and mIPSCs was significantly smaller in nerve-injured rats than in control rats. In addition, the reduction in amplitude of glycinergic IPSCs seemed to be greater than that of GABAergic IPSCs in the spinal cord of nerve-injured rats. Some studies reported that the number of GABA-immunoreactive neurons in the spinal dorsal horn is reduced after nerve injury (Castro-Lopes et al., 1993; Ibuki et al., 1997; Moore et al., 2002) . However, more recent studies have shown that nerve injury does not cause any significant loss of GABAergic and glycinergic neurons in the spinal dorsal horn after (Polgar et al., 2003; Polgar et al., 2005) .
Whereas ionotropic glutamate receptors are responsible for fast excitatory synaptic transmission, mGluRs have an important role in synaptic modulation throughout the central nervous system. Activation of group II mGluRs generally depresses glutamatergic and GABAergic transmission in the normal spinal cord (Gerber et al., 2000; Zhou et al., 2007) , but the functional plasticity of spinal group II mGluRs in the regulation of synaptic transmission in neuropathic pain remains unclear. It has been shown that systemic administration of the group II mGluR agonist (2R,4R)-APDC attenuates tactile allodynia induced by nerve injury in rats (Fisher et al., 2002) .
Others have reported that although intraperitoneal injection of the group II mGluR agonist LY379268 reduces allodynia, it has no significant effect on heat and mechanical hyperalgesia induced by spinal nerve ligation in rats (Simmons et al., 2002) . However, the direct spinal effects of the group II mGluR agonists on neuropathic pain and the associated underlying synaptic mechanisms remain to be investigated. We found that spinally administered DCG-IV dose-dependently attenuated allodynia and hyperalgesia in nerve-injured rats. Unexpectedly, we found that DCG-IV dose-dependently decreased the paw withdrawal threshold in response to noxious mechanical stimulus (i.e., hyperalgesia) in control rats. In addition to their presence on primary afferent terminals (Gerber et al., 2000; Carlton et al., 2001) , group II mGluRs also exist on GABAergic interneurons in the spinal cord (Zhou et al., 2007) . The inhibitory effect of the group II mGluR agonist on GABAergic inhibitory input to spinal dorsal horn neurons may explain the pronociceptive effect of DCG-IV in control animals.
DCG-IV produced a similar degree of inhibition of the monosynaptic eEPSCs evoked from the dorsal root in nerve-injured and control rats, suggesting that peripheral nerve injury had no significant effect on the function of group II mGluRs expressed on primary afferent terminals. However, DCG-IV had a significantly greater inhibitory effect on polysynaptic eEPSCs and sEPSCs in nerve-injured rats than in control rats. Our results are consistent with a recent study showing that the group II mGluR agonist reduces noxious stimulus-evoked glutamate release, measured using microdialysis and HPLC techniques, in the spinal cord of rats with neuropathic pain (Kumar et al., 2010) . It should be noted that potential changes in postsynaptic group II mGluRs in neuropathic pain cannot be ruled out due to the use of GDP-β-S in the internal recording solution in our experiments. Our study suggests that activation of group II mGluRs inhibits nociceptive transmission by reducing glutamatergic input to spinal dorsal horn neurons in a neuropathic pain state.
Another salient finding of our study is that stimulation of group II mGluRs with DCG-IV decreased the frequency of glycinergic sIPSCs and mIPSCs of dorsal horn neurons only in nerve-injured rats. We also found that DCG-IV produced much larger inhibition of glycinergic sIPSCs than glycinergic mIPSCs in nerve-injured rats. Thus, it seems that nerve injury upregulates group II mGluRs on both somatodentritic sites and presynaptic terminals of glycinergic interneurons in the spinal dorsal horn. The mechanisms underlying the distinct effect of the group II mGluRs on glycinergic input in nerve injured rats are not clear. It is possible that nerve injury may selectively upregulate group II mGluRs on a subpopulation of GABAergic-glycinergic interneurons in the spinal cord through increased excitability of a particular group of primary afferents (Lu and Perl, 2003) .
Immunocytochemical results suggest that GABA-and glycine-like immunoreactivities are often colocalized in the spinal dorsal horn (Todd and Sullivan, 1990; Todd, 1996) . However, co-release of GABA and glycine from the same synaptic terminal in the superficial dorsal horn seems rare because direct paired recordings of dorsal horn neurons show that the IPSCs evoked from a single presynaptic terminal were abolished by either the GABAA or glycine receptor antagonist, but not by both (Lu and Perl, 2003; Santos et al., 2007) . Also, our previous studies have shown that muscarinic receptor subtypes and group II and III mGluRs are differentially involved in the control of GABAergic and glycinergic input in the spinal dorsal horn (Zhang et al., 2005; Wang et al., 2006; Zhou et al., 2007; Zhou et al., 2008b) . It has been shown that downregulation of KCC2 and an increase in intracellular chloride concentrations of dorsal horn neurons after sciatic nerve injury can lead to paradoxical excitation and increased firing activity of dorsal horn neurons in response to GABA (Coull et al., 2003) . Hence, inhibition of abnormal GABAergic and glycinergic input by activation of It has been reported that higher concentrations of DCG-IV could stimulate NMDA receptors (Ishida et al., 1993a; Breakwell et al., 1997) . Because activation of presynaptic NMDA receptors increases neurotransmitter release in the spinal cord (Liu et al., 1997; Zhou et al., 2010) , the inhibitory effects of DCG-IV on synaptic transmission observed in our study cannot be explained by its effect on NMDA receptors. Also, it has been shown that 5 μ M DCG-IV does not produce any significant change in intracellular Ca 2+ in all superficial dorsal horn neurons in rats (Heinke and Sandkuhler, 2007) , suggesting that this concentration of DCG-IV does not activate NMDA receptors in the spinal dorsal horn. Nevertheless, it could be argued that the observed pronociceptive effect of DCG-IV in sham control rats may result from stimulation of NMDA receptors. However, we found that blocking the NMDA receptors with AP-5 did not affect the spinal effect of DCG-IV on the pressure withdrawal threshold in sham control rats. Furthermore, we found that AP-5 failed to alter the inhibitory effects of DCG-IV on monosynaptic and polysynaptic eEPSCs and glycinergic sIPSCs in nerve-injured rats. Therefore, the spinal effects of DCG-IV on synaptic transmission and nociception observed in our study are unlikely due to activation of NMDA receptors.
In summary, we demonstrated in this study that activation of group II mGluRs at the spinal level produces a distinct effect on nociception in control and nerve-injured rats. Our findings suggest 
